Ren Jun Lim

Baker McKenzie

Legal Influencer

Q4| 2022

Legal Influencers

Lexology’s Legal Influencers programme recognises firms and authors that provide excellent content within a work area and region. Find out more

  • Q4| 2022 in Healthcare and life sciences - Asia-Pacific
  • Q3| 2022 in Healthcare and life sciences - Asia-Pacific
  • Q3 l 2021 in Healthcare and life sciences - Asia-Pacific

Articles

Results 1 to 5 of 337


Singapore: HSA update on retail-level recall and adverse effects of health products

Singapore - February 2 2023 In December 2022, the Health Sciences Authority (HSA) detected potent ingredients in products marketed for Young children and alerted the…

Andy Leck

Singapore: HSA update on products found by overseas regulators to contain potent ingredients

Singapore - February 2 2023 On 3 January 2023, the Health Sciences Authority (HSA) issued an update on products found and reported by overseas regulators to contain…

Andy Leck

Singapore: Health Sciences Authority issues update on retail-level recall and adverse effects of certain health products

Singapore - January 30 2023 In December 2022, the Health Sciences Authority (HSA) detected potent ingredients in products marketed for young children and alerted the public…

Andy Leck

Singapore: In the matter of a trademark application by Schweiger, Martin Rainer Gabriel [2023] SGIPOS 1

Singapore - January 26 2023 This decision clarifies the distinctiveness requirements for registrability of slogans under the Trade Marks Act and reiterates that slogans are…

Ken Chia, Andy Leck, Alex Toh

Singapore: Class licensing regime for trade promotion games of chance and lotteries and incidental games of chance and lotteries effective 1 February 2023

Singapore - January 26 2023 The passing of the Gambling Control Act 2022 on 1 August 2022 led to the phased introduction of a class licensing regime to regulate certain gambling…

Ken Chia, Andy Leck, Alex Toh